Abdel-Rahman Wael M, Ollikainen Miina, Kariola Reetta, Järvinen Heikki J, Mecklin Jukka-Pekka, Nyström-Lahti Minna, Knuutila Sakari, Peltomäki Päivi
Department of Medical Genetics, University of Helsinki, Helsinki, Finland.
Oncogene. 2005 Feb 24;24(9):1542-51. doi: 10.1038/sj.onc.1208387.
A considerable fraction of families with HNPCC shows no germline mismatch repair (MMR) gene mutations. We previously detected 'hidden' MMR gene defects in 42% of such families, leaving the remaining 58% 'truly' mutation negative. Here, we characterized 50 colorectal carcinomas and five adenomas arising in HNPCC families; 24 truly MMR gene mutation negative and 31 MMR gene mutation positive. Among 31 tumors from MMR gene mutation positive families, 25 (81%) had active Wnt signaling as indicated by aberrant beta-catenin localization with or without CTNNB1 mutations, compared to only 7/18 tumors from MMR gene mutation negative families (39%; P=0.005). CGH studies revealed stable profiles in 9/16 (56%) of MMR gene mutation negative tumors, which was significantly associated with membranous beta-catenin (P=0.005). Tumors with membranous beta-catenin from the MMR gene mutation negative group also showed low frequency of TP53 mutations compared to those with nuclear beta-catenin. Thus, a majority of the MMR gene mutation negative cases exhibited a novel molecular pattern characterized by the paucity of changes in common pathways to colorectal carcinogenesis. This feature distinguishes the MMR gene mutation negative families from both HNPCC families linked to MMR defects and sporadic cases, suggesting the involvement of novel predisposition genes and pathways in such families.
相当一部分遗传性非息肉病性结直肠癌(HNPCC)家族未显示出种系错配修复(MMR)基因突变。我们之前在42%的此类家族中检测到了“隐藏”的MMR基因缺陷,其余58%为“真正”的无突变。在此,我们对HNPCC家族中发生的50例结直肠癌和5例腺瘤进行了特征分析;其中24例为真正的MMR基因无突变,31例为MMR基因突变阳性。在MMR基因突变阳性家族的31例肿瘤中,25例(81%)表现出活跃的Wnt信号,表现为β-连环蛋白定位异常,伴或不伴有CTNNB1突变,相比之下,MMR基因无突变家族的18例肿瘤中只有7例(39%)出现这种情况(P = 0.005)。比较基因组杂交(CGH)研究显示,16例MMR基因无突变肿瘤中有9例(56%)表现出稳定的图谱,这与膜性β-连环蛋白显著相关(P = 0.005)。与核β-连环蛋白的肿瘤相比,MMR基因无突变组中具有膜性β-连环蛋白的肿瘤TP53突变频率也较低。因此,大多数MMR基因无突变病例表现出一种新的分子模式,其特征是结直肠癌发生常见途径中的变化较少。这一特征将MMR基因无突变家族与与MMR缺陷相关的HNPCC家族及散发病例区分开来,提示此类家族中存在新的易感基因和途径。